Company Pegavision Corporation

Equities

6491

TW0006491004

Medical Equipment, Supplies & Distribution

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Ratings for Pegavision Corporation

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Glasses, Spectacles & Contact Lenses

End-of-day quote Taiwan S.E. Other stock markets 06:00:00 2024-04-22 pm EDT			5-day change	1st Jan Change
482.5 ^TWD	+5.35%		+5.23%	+21.69%

Jan. 29	Pegavision Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Pegavision Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Pegavision Corp is primarily engaged in the manufacture and sale of private brand contact lenses, as well as the original equipment manufacturing (OEM) business. The Company distributes its products within domestic market and to overseas markets.

TWD in Million	2022	Weight	2023	Weight	Delta
Contact Lenses 99.4 %	6,309	99.8 %	6,751	99.4 %	+7.01%
Others 0.6 %	12	0.2 %	39	0.6 %	+212.89%

TWD in Million	2022	Weight	2023	Weight	Delta
Other Asian Countries 81.7 %	5,165	81.7 %	5,551	81.7 %	+7.46%
Taiwan 13.0 %	769	12.2 %	881	13.0 %	+14.70%
Other Countries 5.3 %	387	6.1 %	358	5.3 %	-7.66%

Managers	Title	Age	Since
Te Sheng Yang CEO	Chief Executive Officer	-	18-06-13
Ching Hsiang Wang DFI	Director of Finance/CFO	-	13-12-26
Danny Peng IRC	Investor Relations Contact	-	-

Members of the board	Title	Age	Since
Tzu Hsien Tung BRD	Director/Board Member	63	09-08-11
Te Sheng Yang CEO	Chief Executive Officer	-	18-06-13
Ming Tung Kuo CHM	Chairman	-	09-08-11
Ho Hsu Chen BRD	Director/Board Member	-	15-06-15
Jen Lu Yao BRD	Director/Board Member	-	15-06-15
Mu Jung Wen BRD	Director/Board Member	-	18-06-13
Wen Yung Hou BRD	Director/Board Member	-	15-06-15
Shu Yu Li BRD	Director/Board Member	-	17-06-13
Chi-Wan Lai BRD	Director/Board Member	-	21-07-14

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	78,000,000	40,742,000 ( 52.23 %)	0	52.23 %

Name	Equities	%	Valuation
KINSUS INTERCONNECT TECHNOLOGY CORP. 27.22 %	21,233,736	27.22 %	301 M NT$
PEGATRON CORPORATION 8.170 %	6,372,796	8.170 %	90 M NT$
Ming Tung Kuo 1.699 %	1,325,533	1.699 %	19 M NT$
Tzu Hsien Tung 1.412 %	1,101,077	1.412 %	16 M NT$
Te Sheng Yang 0.4646 %	362,360	0.4646 %	5 M NT$
Ho Hsu Chen 0.2723 %	212,374	0.2723 %	3 M NT$
Han Yi Chang 0.2483 %	193,686	0.2483 %	3 M NT$
Jih Sun Securities Investment Trust Co., Ltd. 0.0923 %	71,999	0.0923 %	1 M NT$
State Street Global Advisors Ltd. 0.0376 %	29,314	0.0376 %	415 847 NT$
HSBC Global Asset Management (Taiwan) Ltd. 0.0256 %	19,999	0.0256 %	283 705 NT$

Pegavision Corp.

2nd Floor, Lane 1 No. 5, Shing Yeh Street

333, Taoyuan

http://www.pegavision.com.tw

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

482.5 TWD

Average target price

445.7 TWD

Spread / Average Target

-7.63%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Glasses, Spectacles & Contact Lenses

	1st Jan change	Capi.
PEGAVISION CORPORATION	+21.69%	1.09B
ESSILORLUXOTTICA	+12.78%	97.69B
ALCON INC.	+12.40%	39.6B
THE COOPER COMPANIES, INC.	-3.10%	17.9B
AUTEK CHINA INC.	-23.03%	2.12B
WARBY PARKER INC.	-4.96%	1.46B
MINGYUE OPTICAL LENS CO.,LTD.	-38.53%	759M
MENICON CO., LTD.	-36.57%	740M
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD.	-12.09%	613M
VIZIONFOCUS INC.	+19.80%	468M

Glasses, Spectacles & Contact Lenses